Opioids
The Substance Abuse and Mental Health Services Administration’s Office of Behavioral Health Equity recently published a report on the opioid crisis’ impact on the Hispanic and Latino populations.
The Food and Drug Administration required updated labeling for opioid pain medicine and medicine to treat opioid use disorder to recommend that prescribers discuss naloxone with patients and caregivers.
Drug overdose deaths in the United States rose 4.6% in 2019 to 70,980, including 50,042 involving opioids, according to preliminary data released by the Centers for Disease Control and Prevention.
The AHA releases Stem the Tide: Opioid Stewardship Measurement Implementation Guide, a new data-driven guide as the “how to” part of the Stem the Tide initiative. It connects knowing to doing, offering hospitals and health systems actionable ideas for program development and implementation.
The resources in this area showcase multiple clinical innovations, including how the integration of physical and behavioral health improves patient outcomes and satisfaction, and reduces the total cost of care; how digital solutions can expand access to care and fill gaps in the continuum of care,…
Suicide deaths increased by 37% between 2000 and 2018, with 41 states experiencing statistically significant increases over the same period, according to a pair of reports released this month by the State Health Access Data Assistance Center.
The National Academies of Sciences Engineering, and Medicine released recommendations for improving outcomes and metrics associated with four grant programs funded by the Substance Abuse and Mental Health Services Administration to help reduce opioid-related harm and promote recovery from substance…
In this podcast, Jay Bhatt, former senior vice president and chief medical officer of the AHA, Victor Dzau, president of the National Academy of Medicine, and Ruth Katz, vice president and the executive director of the Health, Medicine, and Society Program at the Aspen Institute discuss how they…
The Centers for Medicare & Medicaid Services recently announced a six-month delay in implementation of its Innovation Center Maternal Opioid Misuse (MOM) Model, due to COVID-19.
The Alliance for Addiction Payment Reform, whose members include the AHA, showcased its value-based payment model for addiction and recovery support services at a briefing for congressional lawmakers and staff.